Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release

During the traumatic brain injury (TBI), improved expression of circulatory miR-21 serves as a diagnostic feature. Low levels of exosome-miR-21 in the brain can effectively improve neuroinflammation and blood–brain barrier (BBB) permeability, reduce nerve apoptosis, restore neural function and ameli...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kefeng Zhai, Hong Duan, Wei Wang, Siyu Zhao, Ghulam Jilany Khan, Mengting Wang, Yuhan Zhang, Kiran Thakur, Xuemei Fang, Chao Wu, Jianbo Xiao, Zhaojun Wei
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/db6f80dbcf4a41e5aa7bc2bd0fbdb55f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db6f80dbcf4a41e5aa7bc2bd0fbdb55f
record_format dspace
spelling oai:doaj.org-article:db6f80dbcf4a41e5aa7bc2bd0fbdb55f2021-12-02T05:01:21ZGinsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release2211-383510.1016/j.apsb.2021.03.032https://doaj.org/article/db6f80dbcf4a41e5aa7bc2bd0fbdb55f2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2211383521001040https://doaj.org/toc/2211-3835During the traumatic brain injury (TBI), improved expression of circulatory miR-21 serves as a diagnostic feature. Low levels of exosome-miR-21 in the brain can effectively improve neuroinflammation and blood–brain barrier (BBB) permeability, reduce nerve apoptosis, restore neural function and ameliorate TBI. We evaluated the role of macrophage derived exosomes-miR-21 (M-Exos-miR-21) in disrupting BBB, deteriorating TBI, and Rg1 interventions. IL-1β-induced macrophages (IIM)-Exos-miR-21 can activate NF-κB signaling pathway and induce the expressions of MMP-1, -3 and -9 and downregulate the levels of tight junction proteins (TJPs) deteriorating the BBB. Rg1 reduced miR-21-5p content in IIM-Exos (RIIM-Exos). The interaction of NMIIA–HSP90 controlled the release of Exos-miR-21, this interaction was restricted by Rg1. Rg1 could inhibit the Exos-miR-21 release in peripheral blood flow to brain, enhancing TIMP3 protein expression, MMPs proteolysis, and restricting TJPs degradation thus protected the BBB integrity. Conclusively, Rg1 can improve the cerebrovascular endothelial injury and hold the therapeutic potential against TBI disease.Kefeng ZhaiHong DuanWei WangSiyu ZhaoGhulam Jilany KhanMengting WangYuhan ZhangKiran ThakurXuemei FangChao WuJianbo XiaoZhaojun WeiElsevierarticleTraumatic brain injuryExosomeMiRNA-21Blood–brain barrierGinsenoside Rg1Nonmuscle myosin IIATherapeutics. PharmacologyRM1-950ENActa Pharmaceutica Sinica B, Vol 11, Iss 11, Pp 3493-3507 (2021)
institution DOAJ
collection DOAJ
language EN
topic Traumatic brain injury
Exosome
MiRNA-21
Blood–brain barrier
Ginsenoside Rg1
Nonmuscle myosin IIA
Therapeutics. Pharmacology
RM1-950
spellingShingle Traumatic brain injury
Exosome
MiRNA-21
Blood–brain barrier
Ginsenoside Rg1
Nonmuscle myosin IIA
Therapeutics. Pharmacology
RM1-950
Kefeng Zhai
Hong Duan
Wei Wang
Siyu Zhao
Ghulam Jilany Khan
Mengting Wang
Yuhan Zhang
Kiran Thakur
Xuemei Fang
Chao Wu
Jianbo Xiao
Zhaojun Wei
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
description During the traumatic brain injury (TBI), improved expression of circulatory miR-21 serves as a diagnostic feature. Low levels of exosome-miR-21 in the brain can effectively improve neuroinflammation and blood–brain barrier (BBB) permeability, reduce nerve apoptosis, restore neural function and ameliorate TBI. We evaluated the role of macrophage derived exosomes-miR-21 (M-Exos-miR-21) in disrupting BBB, deteriorating TBI, and Rg1 interventions. IL-1β-induced macrophages (IIM)-Exos-miR-21 can activate NF-κB signaling pathway and induce the expressions of MMP-1, -3 and -9 and downregulate the levels of tight junction proteins (TJPs) deteriorating the BBB. Rg1 reduced miR-21-5p content in IIM-Exos (RIIM-Exos). The interaction of NMIIA–HSP90 controlled the release of Exos-miR-21, this interaction was restricted by Rg1. Rg1 could inhibit the Exos-miR-21 release in peripheral blood flow to brain, enhancing TIMP3 protein expression, MMPs proteolysis, and restricting TJPs degradation thus protected the BBB integrity. Conclusively, Rg1 can improve the cerebrovascular endothelial injury and hold the therapeutic potential against TBI disease.
format article
author Kefeng Zhai
Hong Duan
Wei Wang
Siyu Zhao
Ghulam Jilany Khan
Mengting Wang
Yuhan Zhang
Kiran Thakur
Xuemei Fang
Chao Wu
Jianbo Xiao
Zhaojun Wei
author_facet Kefeng Zhai
Hong Duan
Wei Wang
Siyu Zhao
Ghulam Jilany Khan
Mengting Wang
Yuhan Zhang
Kiran Thakur
Xuemei Fang
Chao Wu
Jianbo Xiao
Zhaojun Wei
author_sort Kefeng Zhai
title Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
title_short Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
title_full Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
title_fullStr Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
title_full_unstemmed Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
title_sort ginsenoside rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes mir-21 release
publisher Elsevier
publishDate 2021
url https://doaj.org/article/db6f80dbcf4a41e5aa7bc2bd0fbdb55f
work_keys_str_mv AT kefengzhai ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT hongduan ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT weiwang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT siyuzhao ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT ghulamjilanykhan ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT mengtingwang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT yuhanzhang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT kiranthakur ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT xuemeifang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT chaowu ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT jianboxiao ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
AT zhaojunwei ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release
_version_ 1718400859435433984